The Trump administration is taking a bold stance on restricting gender-affirming care for transgender youth in the United States. The latest move by the Centers for Medicare and Medicaid Services involves proposing two new rules that would withhold federal funds for gender-affirming care for minors, including puberty blockers, hormones, and surgery. One of the rules would change the conditions for hospitals and clinics to participate in federal funding programs by disallowing facilities that offer gender-affirming care to minors.
This decision has sparked controversy, with critics arguing that it could force providers to discontinue crucial services or risk losing Medicare and Medicaid funding. The agency also plans to prohibit Medicaid and Children’s Health Insurance Program funds from being used for gender-affirming care for individuals under the age of 19.
The push to restrict access to gender-affirming care for trans youth is not new. Since the early days of President Trump’s term, there have been several attempts to limit Medicaid funding for this type of pediatric care. While some view this care as unnecessary and risky, clinicians, patients, and advocates emphasize that it is evidence-based and often life-saving.
If federal funds are no longer available to cover gender-affirming care for trans youth, states may still have the option to use their own funds for this purpose. However, this could lead to an uneven patchwork of coverage across the country, with some states explicitly excluding trans health care from coverage.
The proposed rule changes could have significant implications for health systems providing gender-affirming care. Many clinics may be forced to comply with the new rules or challenge them in court to continue offering care. Attorneys working to protect access to gender-affirming care are prepared to challenge the new policies and ensure that the rights of trans individuals are upheld.
While there may be a period of legal uncertainty as litigation unfolds, some health systems may choose to suspend gender-affirming care programs to avoid jeopardizing their funding. Patient communities are also pushing back against the restrictions, with families in Connecticut challenging the termination of care at certain healthcare facilities.
The public will have the opportunity to submit comments on the proposed rules for a period of 60 days. The outcome of these developments will have far-reaching implications for the rights and healthcare access of transgender youth in the United States.
